Immune ‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer

ConclusionsThe immune signature constructed is convenient to classify the immunotherapeutic susceptibility of patients with BCa, so as to achieve precision immunotherapy for BCa.

Source: Cancer Medicine - August 24, 2020 Category: Cancer & Oncology Authors: Yejinpeng Wang, Liang Chen, Mengxue Yu, Yayun Fang, Kaiyu Qian, Gang Wang, Lingao Ju, Yu Xiao, Xinghuan Wang Tags: ORIGINAL RESEARCH Source Type: research